An AI-Based Heart Failure Treatment Adviser System

Zhuo Chen1, Elmer Salazar1, Kyle Marple2

  • 1Computer Science DepartmentThe University of Texas at DallasRichardsonTX75080USA.

Insights

A new heart failure treatment adviser system automates complex clinical guidelines. This system provides guideline-compliant recommendations, aiding physicians in managing heart failure effectively.

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Medicine
  • Clinical Decision Support

Background:

  • Heart failure management presents a significant healthcare challenge.
  • Clinical practice guidelines for heart failure are extensive and complex, hindering full compliance.
  • Suboptimal medical practices can arise from difficulties in adhering to intricate guideline rules.

Purpose of the Study:

  • To develop an automated system for heart failure management based on clinical practice guidelines.
  • To create a tool that simulates human-style reasoning for generating guideline-compliant treatment recommendations.
  • To assess the system's performance and potential utility in clinical and educational settings.

Main Methods:

  • Development of a heart failure treatment adviser system using answer set programming.
  • Automation of the complex rules within heart failure clinical practice guidelines.
  • Pilot study involving 21 real and 10 simulated heart failure patients.

Main Results:

  • The system generated guideline-compliant treatment recommendations.
  • Out of 187 recommendations, 176 were agreed upon by expert cardiologists.
  • The system missed eight valid recommendations, attributed to data limitations and expert variability.

Conclusions:

  • The heart failure treatment adviser system demonstrates potential for guideline adherence.
  • The system can function as a point-of-care tool, an educational aid for physicians, and an assessment tool for quality metrics.
  • Further refinement is needed to capture expert decision-making nuances for improved accuracy.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312